Clik here to view.
Titan Spine Announces the First Endoskeleton® Interbody Fusion Cases in...
MEQUON, Wis. Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced the first surgeries in Australia using the...
View ArticleClik here to view.
AstraZeneca to Present Transformative Data at ESMO Asia 2017 Congress from...
SINGAPORE At the ESMO Asia 2017 Congress in Singapore, 17-19 November 2017, AstraZeneca and MedImmune, its global biologics research and development arm, will share ground-breaking results from two...
View ArticleClik here to view.
Jones Packaging, Inc.通过改由Rimini Street为其SAP系统提供支持服务来节省年度维护和ERP升级成本
LAS VEGAS (美国商业资讯)–Rimini Street, Inc. (Nasdaq: RMNI)是全球企业软件产品和服务提供商，也是领先的Oracle和SAP软件产品第三方支持提供商，该公司今天宣布领先的药品包装解决方案提供商Jones Packaging, Inc.已改由Rimini Street为其SAP...
View ArticleClik here to view.
武田薬品、CD30陽性皮膚T細胞リンパ腫の治療薬としてのアドセトリス（ブレンツキシマブ・ベドチン）に対する肯定的見解をCHMPより取得
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社(TSE:...
View ArticleClik here to view.
GI Dynamics to Provide Corporate Update and 2017 Third Quarter Results
BOSTON & SYDNEY GI Dynamics® Inc. (ASX: GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and...
View ArticleClik here to view.
Samsung Bioepis Receives Regulatory Approval for Europe’s First Trastuzumab...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) marketing authorization of ONTRUZANT®, a biosimilar referencing Herceptin® (trastuzumab), for the treatment of...
View ArticleClik here to view.
PeptiDream Announces Discovery Collaboration Agreement with Bayer
KAWASAKI, Japan PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a multi-target discovery collaboration with...
View ArticleClik here to view.
Mitsui Chemicals in Collaboration with Bilcare Introduces Chemipearl™ XSP in...
TOKYO Mitsui Chemicals, Inc. (TOKYO: 4183; President&CEO: Tsutomu Tannowa) announced the successful development of XSP series of ChemipearlTM which is a high performance “Water-based Heat Seal...
View ArticleClik here to view.
三井化学携手江苏中金玛泰医药包装有限公司共同在中国推出Chemipearl™ XSP： 基于水性技术用于医药泡罩包装的新型高性能水性热封胶
东京 (美国商业资讯)– 日本三井化学株式会社（东京：4183， CEO：Tsutomu Tannowa）宣布成功开发了用于医药泡罩包装的高性能水性热封胶ChemipearlTM XSP 系列。ChemipearlTM XSP...
View ArticleClik here to view.
Xona Microfluidics, LLC Issued European Patents for Neuron Research Device
DURHAM, N.C. Xona Microfluidics, LLC, a biotechnology company focused on manufacturing and distributing microfluidic devices to neuroscientists and laboratories worldwide, today announced that the...
View ArticleClik here to view.
Starpharma: NDA Submission for VivaGel® BV in the US
MELBOURNE, Australia Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its US New Drug Application (NDA) submission for VivaGel® BV for both treatment and prevention of BV has been lodged...
View ArticleClik here to view.
Preceptis Medical Announces Series B Financing and Global Growth Strategy for...
MINNEAPOLIS Preceptis Medical, Inc., manufacturer of the Hummingbird TTS (Tympanostomy Tube System) technology that enables a conscious sedation alternative to general anesthesia for placing ear...
View ArticleClik here to view.
Octapharma捐赠3050万国际单位该公司药品 Nuwiq以治疗发展中国家的血友病患者
瑞士拉亨 (美国商业资讯) — 2017: Octapharma欣然宣布，与美国马萨诸塞州North Andover的Project SHARE合作完成一次慈善捐赠，捐赠3050万国际单位的该公司人体细胞系衍生重组第VIII因子制品Nuwiq®。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
オクタファルマ、開発途上国の血友病患者を治療するために当社のNuwiq製剤3050万国際単位を寄付
スイス・ラーヘン （ビジネスワイヤ） — 2017年:オクタファルマは、米国マサチューセッツ州ノースアンドーバーのプロジェクト・シェアと連携して、ヒト細胞株由来の組み換え型第VIII因子製剤Nuwiq®3050万国際単位の慈善寄付を完了したことを発表します。 本プレスリリースではマルチメディアを使用しています。リリースの全文はこちらをご覧ください。：...
View ArticleClik here to view.
Preceptis Medical宣布面向中国的B轮融资和全球增长战略
明尼阿波利斯 (美国商业资讯) — Preceptis Medical, Inc.是Hummingbird...
View ArticleClik here to view.
Puma Biotechnology and Specialised Therapeutics Asia Enter into Exclusive...
LOS ANGELES Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, and Specialised Therapeutics Asia, an international biopharmaceutical company with strategic focus and expertise in...
View ArticleClik here to view.
SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre...
SINGAPORE SCIEX, a global leader in life science analytical technologies, and the Protein and Proteomics Centre (PPC) under the Department of Biological Sciences at the National University of...
View ArticleClik here to view.
米国FDAがSimcyp Simulator (PBPK) の活用範囲を拡大
ニュージャージー州プリンストン （ビジネスワイヤ） — モデルを活かした医薬品開発およびレギュラトリーサイエンスにおけるグローバルリーダーであるサターラ社は本日、米国食品医薬品局 (FDA) が同社のPBPK Simcyp® Population-based Simulator、Simcyp Pediatric SimulatorおよびCardiac Safety...
View ArticleClik here to view.
FDA Renews and Expands its Portfolio of Simcyp Simulator (PBPK) Licenses
PRINCETON, N.J. Certara®, the global leader in model-informed drug development and regulatory science, today announced that the US Food and Drug Administration (FDA) has greatly expanded its use of...
View ArticleClik here to view.
Kyowa Hakko Kirin Announces FDA Acceptance for Filing and Priority Review...
TOKYO Kyowa Hakko Kirin Co., Ltd. (TOKYO:4151) (President and CEO: Nobuo Hanai, “Kyowa Hakko Kirin”) today announces that the U.S. Food and Drug Administration (FDA) has accepted for review the...
View Article